drugset / Trial / NCT00431119

Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid

NCT00431119

RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate the safety and efficacy of oral methylprednisolone combined with azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.

Timeline

Start
1997-10
Primary completion
Completion
2000-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Azathioprine Small molecule 2 mg/kg
Subject Mycophenolate Mofetil Small molecule 1000 mg

Indications